Pain News and Research

Latest Pain News and Research

Adipose tissue, a promising new source of HSPCs

Bone marrow is a leading source of adult stem cells, which are increasingly used for research and therapeutic interventions, but extracting the cells is an arduous and often painful process. Now, researchers have found evidence that fat tissue, known as adipose tissue, may be a promising new source of valuable and easy-to-obtain regenerative cells called hematopoietic stem and progenitor cells (HSPCs), according to astudy prepublished online in Blood, the official journal of the American Society of Hematology.

28 Jan 2010

U.S. study finds improved mortality outcomes for children with rheumatic diseases

A recent study by researchers from the Cleveland Clinic found that the overall mortality rate in the U.S. for all pediatric patients with rheumatic diseases was not worse than the age and sex-adjusted population.

28 Jan 2010

Study shows benefits of endoscopic sinus surgery for patients with chronic sinusitis

Adults with chronic rhinosinusitis -a debilitating inflammation of the nasal passages that lasts for months and keeps coming back - report significantly improved quality of life following minimally invasive endoscopic sinus surgery, according to a new study led by Oregon Health & Science University (OHSU).

28 Jan 2010

Med-IC aims to improve health care for older adults

The Medicare Innovations Collaborative, or Med-IC, is a pilot program that will put some of the nation’s best ideas for improving health care for older adults into practice at hospitals around the country, Mount Sinai School of Medicine and Johns Hopkins University announced.

28 Jan 2010

Heavy backpacks can increase back pain in children

Heavy backpacks place a measurable strain on the spines of children, with heavier loads causing greater spinal strain and increased back pain, reports a study in the January 1 issue of Spine.

28 Jan 2010

Fuisz Pharma develops novel anti-abuse system for using with abuse prone drugs

Fuisz Pharma today announced the development of a novel anti-abuse system intended for use with abuse prone drugs. This system seeks to address the misuse of addictive drugs with a particular emphasis on opiates and is applicable to all dosage forms.

28 Jan 2010

UC-CCHMC partnership receives $3.75M NIAMS grant for musculoskeletal soft tissue repair research

An award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will aid a partnership between the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center (CCHMC) in finding new ways to use adult stem cells to speed repair of musculoskeletal soft tissue injuries.

28 Jan 2010

Abbott declares quarterly dividend of 40 cents per share

Abbott today announced financial results for the fourth quarter ended Dec. 31, 2009.

27 Jan 2010

New disease management initiative in Colorado aims to treat low back pain and improve patient outcomes

HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that by increasing the role of the primary-care physician, the recently launched Colorado Low Back Collaborative (CLBC) aims to treat lower back issues with a more holistic view, and ultimately improve patient outcomes while lowering costs associated with the care of low back pain.

27 Jan 2010

Tel Aviv University expert reviews environmental triggers of common autoimmune diseases

The links between autoimmune diseases, infections, genetics and the environment are complex and mysterious. Why are people who live near airports more susceptible to autoimmune diseases like rheumatoid arthritis and lupus? How do hormones in meat trigger the onset of a disease?

27 Jan 2010

Potential risk factors in skipping insulin injections

More than half of people with diabetes who take insulin injections to control their diabetes say they have intentionally skipped an injection, with one-fifth of them reporting that they do so "sometimes" or "often," according to a study being published this month in Diabetes Care.

27 Jan 2010

Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

Patients with gastrointestinal stromal tumours (GIST) can now take action at an earlier stage of this rare form of cancer to reduce the risk of their disease returning following surgery. Novartis Pharmaceuticals Canada announced today that Gleevec* (imatinib mesylate) has received conditional approval by Health Canada for the adjuvant (post-surgical) treatment of adult patients who are at intermediate to high risk of disease recurrence following the surgical removal of GIST.

27 Jan 2010

FDA approves the NDA of Roxane Laboratories' Morphine Sulfate Oral Solution CII

Roxane Laboratories, Inc. announced today the New Drug Application (NDA) approval of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL) 30mL and 120mL bottles as of January 25th, 2010 by the Food and Drug Administration.

27 Jan 2010

Ablation therapy better than drug therapy for heart rhythm disorder

Treating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, according to a landmark study published in the Jan. 27 issue of the Journal of the American Medical Association (JAMA).

27 Jan 2010

Preoperative CT may help reduce unnecessary surgeries in women with suspected acute appendicitis

Preoperative computed tomography (CT) may help reduce unnecessary surgeries in women of reproductive age with suspected acute appendicitis, according to a new study appearing in the February issue of the journal Radiology.

27 Jan 2010

EpiCept's NP-1 for treatment of PHN receives FDA orphan drug designation

EpiCept Corporation announced today that EpiCeptTM NP-1 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of post-herpetic neuralgia (PHN). NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies.

27 Jan 2010

FDA approves oral pain relief solution for opioid-tolerant patients

The U.S. Food and Drug Administration today approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients. This medicine will be available in 100 milligrams per 5 mL or 20 milligrams per 1 mL.

27 Jan 2010

FDA approves Victoza to treat type 2 diabetes in some adults

The U.S. Food and Drug Administration today approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults.

27 Jan 2010

Twenty nations meet in Montreal to discuss Haiti recovery; Haitian officials increase Port-Au-Prince death toll estimate

Officials from 20 countries are meeting in Montreal, Canada, Monday "to discuss long-term reconstruction and arrangements for a donor conference to be held in March," the U.N. said, Bloomberg reports (Gaouette/Craze, 1/25). "U.S. Secretary of State Hillary Clinton, Canadian Prime Minister Stephen Harper, French Foreign Minister Bernard Kouchner and others will examine eventual debt forgiveness and" a strategy for rebuilding Haiti at the one-day gathering, according to Reuters (Palmer, 1/25).

27 Jan 2010

BioElectronics signs contract with YesDTC Holdings to enter the Japanese market

BioElectronics Corp., the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the signing of a contract with YesDTC Holdings, Inc. (YESD.OB) to enter the Japanese market and receipt of the single largest product order and revenue commitment in company history.

26 Jan 2010

Pain News and Research

Latest Pain News and Research

Adipose tissue, a promising new source of HSPCs

U.S. study finds improved mortality outcomes for children with rheumatic diseases

Study shows benefits of endoscopic sinus surgery for patients with chronic sinusitis

Med-IC aims to improve health care for older adults

Heavy backpacks can increase back pain in children

Fuisz Pharma develops novel anti-abuse system for using with abuse prone drugs

UC-CCHMC partnership receives $3.75M NIAMS grant for musculoskeletal soft tissue repair research

Abbott declares quarterly dividend of 40 cents per share

New disease management initiative in Colorado aims to treat low back pain and improve patient outcomes

Tel Aviv University expert reviews environmental triggers of common autoimmune diseases

Potential risk factors in skipping insulin injections

Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

FDA approves the NDA of Roxane Laboratories' Morphine Sulfate Oral Solution CII

Ablation therapy better than drug therapy for heart rhythm disorder

Preoperative CT may help reduce unnecessary surgeries in women with suspected acute appendicitis

EpiCept's NP-1 for treatment of PHN receives FDA orphan drug designation

FDA approves oral pain relief solution for opioid-tolerant patients

FDA approves Victoza to treat type 2 diabetes in some adults

Twenty nations meet in Montreal to discuss Haiti recovery; Haitian officials increase Port-Au-Prince death toll estimate

BioElectronics signs contract with YesDTC Holdings to enter the Japanese market

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Pain News and Research

Latest Pain News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in